JPMorgan Adjusts Price Target on Pfizer (NYSE:PFE) to $39 From $41By legume / August 2, 2023 / JPMorgan, Pfizer JPMorgan Adjusts Price Target on Pfizer (NYSE:PFE) to $39 From $41, Maintains Neutral Rating.